Former director (through FY2025) · Dianthus Therapeutics, Inc. (DNTH)

Tomas Kiselak director compensation at Dianthus (FY2025): $9.3K

Fiscal year 2025 director compensation for Tomas Kiselak at Dianthus Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 9, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Tomas Kiselak’s full pay file as a PDF — free

More than this page: up to 10 years of Tomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Tomas Kiselak and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Dianthus Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Dianthus Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$9,303—$0—$9,303
FY2024$55,000—$182,408—$237,408
FY2023$16,628—$54,628—$71,256

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dianthus Therapeutics, Inc. DEF 14A filed April 9, 2026, accession 0001690585-26-000012, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Dianthus Therapeutics, Inc. filed document, accession 0001690585-26-000012. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2026.

Get the Dianthus Therapeutics Board Governance Report

$9,303 Tomas Kiselak, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 9, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Dianthus Therapeutics pays directors a $40,000 cash retainer.

The rest of the Dianthus Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alison F. LawtonIndependent Director$259,787
Anne McGeorgeIndependent Director$232,382
Jonathan Violin, Ph.DIndependent Director$217,476
Marino GarciaDirector—
Paula SoteropoulosIndependent Director$231,787
Simon Read, Ph.DIndependent Director$382,309
Steven Romano, M.DIndependent Director$225,647
Sujay KangoIndependent Director$418,860

The full Dianthus Therapeutics compensation record

free company brief

This page is one director within Dianthus Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Dianthus Therapeutics proxy · each links to its own free brief

Order DNTH

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report